Effect of Botulinum Toxin a Injection in Treatment of Recession RT1 and RT2
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Botulinum toxin-A injection, Coronally advanced flap.
- Who it may be relevant to
- Registry conditions: Gingival Recession. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Botulinum Toxin -A Injection in Mentalis Muscle with Coronally Advanced Flap and De-epithelized Free Gingival Graft in Treatment of RT1 , RT2 Gingival Recession _Randomized Control Trial
Overview
The goal of this study type: clinical trial\] is to learn the effect of Botulinum Toxin \_A injection in treatment of RT1andRT2 Gingival recession in lower anterior teeth . Primary outcome is keratinzed tissue width. Researchers will compare Coronally Advanced flap with De-epithelized free gingival graft and Botulinum toxin-A injection in Mentalis muscle with coronally advanced flap with De-epithelized free gingival graft alone . The outcome will be measured at baseline, after 3 months and after 6 mobths \_medical history * 3 mm horizontal incisions, then two vertical incisions * deepitheliztion of anatomical papillae * superficial and deep incisions * harvesting DFGG * Suturing * BOTOX injection
Interventions
- Procedure Botulinum toxin-A injection
Botulinum toxin-A Injection Mentalis muscle in lower anterior teeth - Procedure Coronally advanced flap
Coronally Advanced Flap andDe-epithelized Free Gingival Graft
Primary outcome measures
- Keratinized tissue width [Time frame: Measured at baseline ,3months ,6 months]
Eligibility criteria
Inclusion criteria
- Single or multiple RT1, RT2 GR patient
- patients ≥18 years
- systemically healthy, full mouth plaque score, full mouth bleeding score ≤ 15% after phase I therapy
- clinical indication and/or patient request for recession coverage
- well motivated patients, maintaining oral hygiene throughout study
Exclusion criteria
- Pregnant or lactating women
- Smokers' patients
- Teeth with cervical restorations/abrasion.
- Patients had a systemic condition affect blood components and healing
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06842290 · PER3,3,2